Brocco M - Search Results

1

Blockade of serotonin 5-HT1B and 5-HT2A receptors suppresses the induction of locomotor activity by 5-HT reuptake inhibitors, citalopram and fluvoxamine, in NMRI mice exposed to a novel environment: a comparison to other 5-HT receptor subtypes.

Millan MJ, Veiga S, Girardon S, Brocco M. Millan MJ, et al. Among authors: brocco m. Psychopharmacology (Berl). 2003 Aug;168(4):397-409. doi: 10.1007/s00213-003-1389-y. Epub 2003 Apr 30. Psychopharmacology (Berl). 2003. PMID: 12721776

2

Induction of hyperlocomotion in mice exposed to a novel environment by inhibition of serotonin reuptake. A pharmacological characterization of diverse classes of antidepressant agents.

Brocco M, Dekeyne A, Veiga S, Girardon S, Millan MJ. Brocco M, et al. Pharmacol Biochem Behav. 2002 Apr;71(4):667-80. doi: 10.1016/s0091-3057(01)00701-8. Pharmacol Biochem Behav. 2002. PMID: 11888558

3

The role of dopamine D3 compared with D2 receptors in the control of locomotor activity: a combined behavioural and neurochemical analysis with novel, selective antagonists in rats.

Millan MJ, Seguin L, Gobert A, Cussac D, Brocco M. Millan MJ, et al. Among authors: brocco m. Psychopharmacology (Berl). 2004 Jul;174(3):341-57. doi: 10.1007/s00213-003-1770-x. Epub 2004 Feb 19. Psychopharmacology (Berl). 2004. PMID: 14985929

4

Anxiolytic properties of agomelatine, an antidepressant with melatoninergic and serotonergic properties: role of 5-HT2C receptor blockade.

Millan MJ, Brocco M, Gobert A, Dekeyne A. Millan MJ, et al. Among authors: brocco m. Psychopharmacology (Berl). 2005 Feb;177(4):448-58. doi: 10.1007/s00213-004-1962-z. Epub 2004 Jul 31. Psychopharmacology (Berl). 2005. PMID: 15289999

5

S32006, a novel 5-HT2C receptor antagonist displaying broad-based antidepressant and anxiolytic properties in rodent models.

Dekeyne A, Mannoury la Cour C, Gobert A, Brocco M, Lejeune F, Serres F, Sharp T, Daszuta A, Soumier A, Papp M, Rivet JM, Flik G, Cremers TI, Muller O, Lavielle G, Millan MJ. Dekeyne A, et al. Among authors: brocco m. Psychopharmacology (Berl). 2008 Sep;199(4):549-68. doi: 10.1007/s00213-008-1177-9. Epub 2008 Jun 4. Psychopharmacology (Berl). 2008. PMID: 18523738

6

S 15535, a novel benzodioxopiperazine ligand of serotonin (5-HT)1A receptors: II. Modulation of hippocampal serotonin release in relation to potential anxiolytic properties.

Millan MJ, Hjorth S, Samanin R, Schreiber R, Jaffard R, De Ladonchamps B, Veiga S, Goument B, Peglion JL, Spedding M, Brocco M. Millan MJ, et al. Among authors: brocco m. J Pharmacol Exp Ther. 1997 Jul;282(1):148-61. J Pharmacol Exp Ther. 1997. PMID: 9223550

7

The selective serotonin (5-HT)1A receptor ligand, S15535, displays anxiolytic-like effects in the social interaction and Vogel models and suppresses dialysate levels of 5-HT in the dorsal hippocampus of freely-moving rats. A comparison with other anxiolytic agents.

Dekeyne A, Brocco M, Adhumeau A, Gobert A, Millan MJ. Dekeyne A, et al. Among authors: brocco m. Psychopharmacology (Berl). 2000 Sep;152(1):55-66. doi: 10.1007/s002130000449. Psychopharmacology (Berl). 2000. PMID: 11041316

8

Stereospecific blockade of marble-burying behaviour in mice by selective, non-peptidergic neurokinin1 (NK1) receptor antagonists.

Millan MJ, Girardon S, Mullot J, Brocco M, Dekeyne A. Millan MJ, et al. Among authors: brocco m. Neuropharmacology. 2002 Apr;42(5):677-84. doi: 10.1016/s0028-3908(02)00021-7. Neuropharmacology. 2002. PMID: 11985826

9

The Vogel conflict test: procedural aspects, gamma-aminobutyric acid, glutamate and monoamines.

Millan MJ, Brocco M. Millan MJ, et al. Among authors: brocco m. Eur J Pharmacol. 2003 Feb 28;463(1-3):67-96. doi: 10.1016/s0014-2999(03)01275-5. Eur J Pharmacol. 2003. PMID: 12600703 Review.

10

S32504, a novel naphtoxazine agonist at dopamine D3/D2 receptors: III. Actions in models of potential antidepressive and anxiolytic activity in comparison with ropinirole.

Millan MJ, Brocco M, Papp M, Serres F, La Rochelle CD, Sharp T, Peglion JL, Dekeyne A. Millan MJ, et al. Among authors: brocco m. J Pharmacol Exp Ther. 2004 Jun;309(3):936-50. doi: 10.1124/jpet.103.062463. Epub 2004 Feb 20. J Pharmacol Exp Ther. 2004. PMID: 14978196 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

103 results

Search Page